America Great Health (AAGH)

USD 0.0

(-18.18%)

Long Term Debt Summary of America Great Health

  • America Great Health's latest annual long term debt in 2023 was 1.12 Million USD , up 6.45% from previous year.
  • America Great Health's latest quarterly long term debt in 2024 Q3 was 1.12 Million USD , down 0.0% from previous quarter.
  • America Great Health reported annual long term debt of 1.05 Million USD in 2022, up 60.25% from previous year.
  • America Great Health reported annual long term debt of 658.41 Thousand USD in 2021, down 0.0% from previous year.
  • America Great Health reported quarterly long term debt of 1.12 Million USD for 2024 Q1, down 0.0% from previous quarter.
  • America Great Health reported quarterly long term debt of 1.12 Million USD for 2024 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of America Great Health (2023 - 2011)

Historical Annual Long Term Debt of America Great Health (2023 - 2011)

Year Long Term Debt Long Term Debt Growth
2023 1.12 Million USD 6.45%
2022 1.05 Million USD 60.25%
2021 658.41 Thousand USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD -100.0%
2016 531.97 Thousand USD 0.0%
2015 - USD 0.0%
2014 - USD -100.0%
2013 140 Thousand USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%

Peer Long Term Debt Comparison of America Great Health

Name Long Term Debt Long Term Debt Difference
Ampio Pharmaceuticals, Inc. - USD -Infinity%
Aridis Pharmaceuticals, Inc. 1.29 Million USD 13.07%
Biora Therapeutics, Inc. 43.73 Million USD 97.432%
Bio-Path Holdings, Inc. 10 Thousand USD -11131.38%
Better Therapeutics, Inc. 10.34 Million USD 89.146%
Calithera Biosciences, Inc. 136 Thousand USD -725.837%
Comera Life Sciences Holdings, Inc. 120.3 Thousand USD -833.599%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
Eloxx Pharmaceuticals, Inc. 8.69 Million USD 87.078%
Evelo Biosciences, Inc. 48.87 Million USD 97.702%
Evolutionary Genomics, Inc. 3.74 Million USD 70.0%
Finch Therapeutics Group, Inc. 28.4 Million USD 96.046%
Galera Therapeutics, Inc. 151.04 Million USD 99.256%
Innovation1 Biotech Inc. 218.99 Thousand USD -412.851%
Kiromic BioPharma, Inc. 911.5 Thousand USD -23.219%
Molecular Templates, Inc. 9.74 Million USD 88.471%
Navidea Biopharmaceuticals, Inc. 1.87 Million USD 39.994%
NexImmune, Inc. - USD -Infinity%
Orgenesis Inc. 19.06 Million USD 94.11%
Panbela Therapeutics, Inc. 4.19 Million USD 73.22%
Point of Care Nano-Technology, Inc. - USD -Infinity%
PaxMedica, Inc. Common Stock - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 104.33 Million USD 98.924%
Statera Biopharma, Inc. 11.43 Million USD 90.175%
TRACON Pharmaceuticals, Inc. 732 Thousand USD -53.434%
Trevena, Inc. 35.23 Million USD 96.812%
Vaxxinity, Inc. 13.26 Million USD 91.531%
Vaccinex, Inc. 26 Thousand USD -4219.762%
Vicapsys Life Sciences, Inc. - USD -Infinity%
Viracta Therapeutics, Inc. - USD -Infinity%
ZIVO Bioscience, Inc. - USD -Infinity%